Search research articles
Contact Us
Filters
Showing results (201-210 of 501) with videos related to
Page
of 51
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 26, 2008
Short German guidelines: squamous cell carcinoma
Helmut Breuninger, Friedrich Bootz, Axel Hauschild, et al.
Journal of the American Academy of Dermatology
|
July 6, 2007
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma
Thomas K Eigentler, Anne Kamin, Benjamin M Weide, et al.
Cancer
|
June 22, 2010
High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanoma
Benjamin Weide, Evelyna Derhovanessian, Annette Pflugfelder, et al.
International Journal of Dermatology
|
January 20, 2011
Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors
Yevgeniy Balagula, Claus Garbe, Patricia L Myskowski, et al.
Targeted Oncology
|
February 8, 2021
Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors
Maximilian Gassenmaier, Max M Lenders, Andrea Forschner, et al.
Plos One
|
November 28, 2017
Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma
Maria Rita Gaiser, Alexander Skorokhod, Diana Gransheier, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 24, 2017
18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start
Ferdinand Seith, Andrea Forschner, Holger Schmidt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 16, 2021
Theresa Steeb, Markus Follmann, Thomas Langer, et al.
Acta Dermato-Venereologica
|
September 7, 2021
Micrographic Surgery Allows Fascia Preservation in Dermatofibro-sarcoma Protuberans
Maximilian Gassenmaier, Erik Weber, Ulrike Leiter, et al.
International Journal of Cancer
|
February 11, 2012
Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells
Sarah Schott, Heike Niessner, Tobias Sinnberg, et al.
Page
of 51
Search research articles
Search
Showing results (201-210 of 501) with videos related to
Sort By:
Page
of 51
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 26, 2008
Short German guidelines: squamous cell carcinoma
Helmut Breuninger, Friedrich Bootz, Axel Hauschild, et al.
Journal of the American Academy of Dermatology
|
July 6, 2007
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma
Thomas K Eigentler, Anne Kamin, Benjamin M Weide, et al.
Cancer
|
June 22, 2010
High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanoma
Benjamin Weide, Evelyna Derhovanessian, Annette Pflugfelder, et al.
International Journal of Dermatology
|
January 20, 2011
Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors
Yevgeniy Balagula, Claus Garbe, Patricia L Myskowski, et al.
Targeted Oncology
|
February 8, 2021
Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors
Maximilian Gassenmaier, Max M Lenders, Andrea Forschner, et al.
Plos One
|
November 28, 2017
Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma
Maria Rita Gaiser, Alexander Skorokhod, Diana Gransheier, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 24, 2017
18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start
Ferdinand Seith, Andrea Forschner, Holger Schmidt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 16, 2021
Theresa Steeb, Markus Follmann, Thomas Langer, et al.
Acta Dermato-Venereologica
|
September 7, 2021
Micrographic Surgery Allows Fascia Preservation in Dermatofibro-sarcoma Protuberans
Maximilian Gassenmaier, Erik Weber, Ulrike Leiter, et al.
International Journal of Cancer
|
February 11, 2012
Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells
Sarah Schott, Heike Niessner, Tobias Sinnberg, et al.
Page
of 51